Search
Now showing items 1-2 of 2
After the GEMINI-ACS-1 trial
(TURKISH SOC CARDIOLOGY, 2017)
The GEMINI-ACS-1 trial has recently been published. It was designed to test whether low dose rivaroxaban as an antithrombotic agent is as safe as aspirin in patients with acute coronary syndromes (ACS). The trial is important ...
Iron deficiency and anemia in heart failure
(TURKISH SOC CARDIOLOGY, 2017)
Heart failure is an important community health problem. Prevalence and incidence of heart failure have continued to rise over the years. Despite recent advances in heart failure therapy, prognosis is still poor, rehospitalization ...